These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1657617)

  • 1. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality.
    Lesslauer W; Tabuchi H; Gentz R; Brockhaus M; Schlaeger EJ; Grau G; Piguet PF; Pointaire P; Vassalli P; Loetscher H
    Eur J Immunol; 1991 Nov; 21(11):2883-6. PubMed ID: 1657617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    Mohler KM; Torrance DS; Smith CA; Goodwin RG; Stremler KE; Fung VP; Madani H; Widmer MB
    J Immunol; 1993 Aug; 151(3):1548-61. PubMed ID: 8393046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections.
    Garcia I; Miyazaki Y; Araki K; Araki M; Lucas R; Grau GE; Milon G; Belkaid Y; Montixi C; Lesslauer W
    Eur J Immunol; 1995 Aug; 25(8):2401-7. PubMed ID: 7664802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel xanthine derivative counteracting in vivo tumor necrosis factor alpha toxicity in mice.
    Niehörster M; Schönharting M; Wendel A
    Circ Shock; 1992 Aug; 37(4):270-3. PubMed ID: 1446384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.
    Libert C; Vink A; Coulie P; Brouckaert P; Everaerdt B; Van Snick J; Fiers W
    Eur J Immunol; 1992 Oct; 22(10):2625-30. PubMed ID: 1327800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
    Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
    J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does high mobility group 1 protein function as a late mediator for LPS- or TNF-induced shock in galactosamine-sensitized mice?
    Hasunuma R; Maruyama H; Takimoto H; Ryll R; Tanaka S; Kumazawa Y
    J Endotoxin Res; 2002; 8(5):391-8. PubMed ID: 12537698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.
    Marchant A; Bruyns C; Vandenabeele P; Ducarme M; Gérard C; Delvaux A; De Groote D; Abramowicz D; Velu T; Goldman M
    Eur J Immunol; 1994 May; 24(5):1167-71. PubMed ID: 8181527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock.
    Jilg S; Barsig J; Leist M; Küsters S; Volk HD; Wendel A
    J Pharmacol Exp Ther; 1996 Jul; 278(1):421-31. PubMed ID: 8764378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
    Scallon BJ; Trinh H; Nedelman M; Brennan FM; Feldmann M; Ghrayeb J
    Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock.
    Bertini R; Delgado R; Faggioni R; Gascon MP; Ythier A; Ghezzi P
    Eur Cytokine Netw; 1993; 4(1):39-42. PubMed ID: 8387827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
    Wysocka M; Kubin M; Vieira LQ; Ozmen L; Garotta G; Scott P; Trinchieri G
    Eur J Immunol; 1995 Mar; 25(3):672-6. PubMed ID: 7705395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
    Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
    Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of ciliary neurotrophic factor (CNTF) in a model of endotoxic shock: action mechanisms and role of CNTF receptor alpha.
    Demitri MT; Benigni F; Meazza C; Zinetti M; Fratelli M; Villa P; Acheson A; Panayotatos N; Ghezzi P
    J Inflamm; 1998; 48(2):47-55. PubMed ID: 9656141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor.
    Brouckaert P; Everaerdt B; Fiers W
    Eur J Immunol; 1992 Apr; 22(4):981-6. PubMed ID: 1532365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effects of a biscoclaurine alkaloid, cepharanthine, on endotoxin or tumor necrosis factor-alpha-induced septic shock symptoms: involvement of from cell death in L929 cells and nitric oxide production in raw 264.7 cells.
    Sakaguchi S; Furusawa S; Wu J; Nagata K
    Int Immunopharmacol; 2007 Feb; 7(2):191-7. PubMed ID: 17178386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
    Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
    Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge.
    Parmely MJ; Zhou WW; Edwards CK; Borcherding DR; Silverstein R; Morrison DC
    J Immunol; 1993 Jul; 151(1):389-96. PubMed ID: 8326132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.